News
EVAX
2.910
+1.75%
0.050
Evaxion A/S Submits Amendment To Its Registration Statement On Form F-1 Regarding 2025 Debt Settlement Agreement With The European Investment Bank With SEC
Benzinga · 2d ago
Weekly Report: what happened at EVAX last week (1102-1106)?
Weekly Report · 2d ago
Evaxion Reports Strong Immune Responses in EVX-01 Phase 2 Data
TipRanks · 5d ago
Evaxion Biotech announces biomarker data from Phase 2 EVX-01 trial
TipRanks · 5d ago
Evaxion Announces Data From Its Phase 2 Study Of EVX- In Participants With Advanced Melanoma Demonstrates Induced Immune Responses, Underlines Predictive Performance
Benzinga · 5d ago
Evaxion A/S to Present New Target Validation Data for EVX-04 at ASH 2026 Meeting
NASDAQ · 6d ago
Evaxion’s EVX-01 Melanoma Study Reaches a Key Update—What Investors Should Know
TipRanks · 11/04 16:30
Evaxion Announces New EVX-04 AML Vaccine Validation Data
TipRanks · 11/04 14:29
Evaxion A/S Raises $775,068 in Net Proceeds via ATM Offering of 201,198 ADSs
NASDAQ · 11/04 14:05
Evaxion To Demonstrate New Data For EVX-04 Vaccine At American Society Of Hematology Annual Meeting
Benzinga · 11/04 14:03
Evaxion Raises $775,068 Through October ADS Sales
TipRanks · 11/04 11:57
Evaxion A/S to Present Biomarker Data from phase 2 Trial of EVX-01 at SITC 2026
NASDAQ · 11/03 21:08
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 11/03 17:30
Evaxion to Present EVX-01 Biomarker Data at SITC 2026
TipRanks · 11/03 14:49
Weekly Report: what happened at EVAX last week (1026-1030)?
Weekly Report · 11/02 10:11
Evaxion Wins 2026 International Prix Galien Award for AI-Immunology Platform
TipRanks · 10/30 11:27
Weekly Report: what happened at EVAX last week (1019-1023)?
Weekly Report · 10/26 10:11
Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Bioline RX Ltd Sponsored ADR (BLRX) and Evaxion Biotech (EVAX)
TipRanks · 10/23 17:30
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/23 12:05
Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01
NASDAQ · 10/23 11:12
More
Webull provides a variety of real-time EVAX stock news. You can receive the latest news about Evaxion AS through multiple platforms. This information may help you make smarter investment decisions.
About EVAX
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.